IDR 1060.0
(-2.3%)
Year | Total Liabilities | Total Liabilities Growth |
---|---|---|
2023 | 111.44 Billion IDR | -31.03% |
2022 | 161.58 Billion IDR | -51.74% |
2021 | 334.81 Billion IDR | 7.92% |
2020 | 310.25 Billion IDR | 118.13% |
2019 | 142.23 Billion IDR | 77.03% |
2018 | 80.34 Billion IDR | 32.24% |
2017 | 60.75 Billion IDR | -32.73% |
2016 | 90.31 Billion IDR | 7.14% |
2015 | 84.29 Billion IDR | 8.73% |
2014 | 77.53 Billion IDR | 0.0% |
Year | Total Liabilities | Total Liabilities Growth |
---|---|---|
2024 Q3 | 173.44 Billion IDR | 6.49% |
2024 Q1 | 130.78 Billion IDR | 17.35% |
2024 Q2 | 162.86 Billion IDR | 24.53% |
2023 Q3 | 115.72 Billion IDR | -43.36% |
2023 Q4 | 111.44 Billion IDR | -3.7% |
2023 FY | 111.44 Billion IDR | -31.03% |
2023 Q1 | 125.45 Billion IDR | -22.36% |
2023 Q2 | 204.33 Billion IDR | 62.87% |
2022 Q3 | 228.36 Billion IDR | -38.03% |
2022 Q1 | 309.07 Billion IDR | -7.69% |
2022 Q4 | 161.58 Billion IDR | -29.24% |
2022 FY | 161.58 Billion IDR | -51.74% |
2022 Q2 | 368.5 Billion IDR | 19.23% |
2021 FY | 334.81 Billion IDR | 7.92% |
2021 Q2 | 463.28 Billion IDR | 30.45% |
2021 Q4 | 334.81 Billion IDR | -20.08% |
2021 Q3 | 418.93 Billion IDR | -9.57% |
2021 Q1 | 355.14 Billion IDR | 14.47% |
2020 Q2 | 141.58 Billion IDR | -15.32% |
2020 Q1 | 167.2 Billion IDR | 17.56% |
2020 FY | 310.25 Billion IDR | 118.13% |
2020 Q3 | 248.17 Billion IDR | 75.29% |
2020 Q4 | 310.25 Billion IDR | 25.01% |
2019 Q3 | 156.3 Billion IDR | 1.96% |
2019 Q1 | 119 Billion IDR | 48.12% |
2019 Q4 | 142.23 Billion IDR | -9.0% |
2019 FY | 142.23 Billion IDR | 77.03% |
2019 Q2 | 153.29 Billion IDR | 28.82% |
2018 Q1 | 56.8 Billion IDR | -6.51% |
2018 Q4 | 80.34 Billion IDR | -10.33% |
2018 Q3 | 89.59 Billion IDR | 11.43% |
2018 Q2 | 80.4 Billion IDR | 41.55% |
2018 FY | 80.34 Billion IDR | 32.24% |
2017 Q1 | - IDR | -100.0% |
2017 FY | 60.75 Billion IDR | -32.73% |
2017 Q3 | 54.85 Billion IDR | -30.26% |
2017 Q4 | 60.75 Billion IDR | 10.75% |
2017 Q2 | 78.65 Billion IDR | 0.0% |
2016 Q1 | - IDR | 0.0% |
2016 Q4 | 90.31 Billion IDR | 0.0% |
2016 FY | 90.31 Billion IDR | 7.14% |
2015 FY | 84.29 Billion IDR | 8.73% |
2014 FY | 77.53 Billion IDR | 0.0% |
Name | Total Liabilities | Total Liabilities Difference |
---|---|---|
PT Hetzer Medical Indonesia Tbk | 11.96 Billion IDR | -831.116% |
PT Jayamas Medica Industri Tbk | 336.07 Billion IDR | 66.838% |
Maja Agung Latexindo Tbk. | 61.38 Billion IDR | -81.552% |